Related Experiment Videos
Complications associated with infusion pumps implanted for spasticity
1Department of Neurosurgery, University of Wisconsin, Madison, USA.
Stereotactic and Functional Neurosurgery
|January 1, 1995
Summary
Implanted infusion pumps effectively treat spasticity. However, complications arose in 62% of patients, highlighting the need for careful pump selection and informed consent regarding potential risks.
Area of Science:
- Neurosurgery
- Pharmacology
- Biomedical Engineering
Background:
- Intrathecal infusion pumps are a recognized treatment for spasticity.
- Both surgical implantation and hardware can lead to complications.
Purpose of the Study:
- To analyze the complication rates associated with implanted intrathecal infusion pumps over an 8-year period.
- To compare complication incidence between different pump models.
Main Methods:
- Retrospective review of 34 intrathecal pump implantations in 30 patients.
- Medications used included morphine and baclofen for spasticity management.
- Data collected on overall and device-specific complication rates.
Main Results:
- An overall complication incidence of 62% was observed.
- Infusaid pumps had a 24% complication rate.
- Medtronic pumps exhibited a 167% complication rate.
Conclusions:
- Complication rates vary significantly between intrathecal pump systems.
- Understanding complication incidence is crucial for patient informed consent.
- Pump and connector selection should consider potential risks and complication profiles.